Biomarker Discovery with Quantum Neural Networks: A Case-study in CTLA4-Activation Pathways
arXiv:2306.01745 · doi:10.1186/s12859-024-05755-0
Abstract
Biomarker discovery is a challenging task due to the massive search space. Quantum computing and quantum Artificial Intelligence (quantum AI) can be used to address the computational problem of biomarker discovery tasks. We propose a Quantum Neural Networks (QNNs) architecture to discover biomarkers for input activation pathways. The Maximum Relevance, Minimum Redundancy (mRMR) criteria is used to score biomarker candidate sets. Our proposed model is economical since the neural solution can be delivered on constrained hardware. We demonstrate the proof of concept on four activation pathways associated with CTLA4, including (1) CTLA4-activation stand-alone, (2) CTLA4-CD8A-CD8B co-activation, (3) CTLA4-CD2 co-activation, and (4) CTLA4-CD2-CD48-CD53-CD58-CD84 co-activation. The model indicates new biomarkers associated with the mutational activation of CLTA4-associated pathways, including 20 genes: CLIC4, CPE, ETS2, FAM107A, GPR116, HYOU1, LCN2, MACF1, MT1G, NAPA, NDUFS5, PAK1, PFN1, PGAP3, PPM1G, PSMD8, RNF213, SLC25A3, UBA1, and WLS. We open source the implementation at: https://github.com/namnguyen0510/Biomarker-Discovery-with-Quantum-Neural-Networks.
References in corpus (9)
- PyTorch: An Imperative Style, High-Performance Deep Learning Library
- Quantum machine learning in feature Hilbert spaces
- Parameterized quantum circuits as machine learning models
- The effect of data encoding on the expressive power of variational quantum machine learning models
- Continuous-variable quantum neural networks
- PennyLane: Automatic differentiation of hybrid quantum-classical computations
- Is quantum advantage the right goal for quantum machine learning?
- Contrastive Self-supervised Neural Architecture Search
- Multi-Beholder: Biomarker Prediction for Low-Grade Glioma with Multiple Instance Learning and One-Class Classification